Stokes Capital Advisors’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.29M | Sell |
35,871
-32,379
| -47% | -$2.83M | 0.7% | 51 |
|
|
2026
Q1 | $5.82M | Sell |
68,250
-10,500
| -13% | -$936K | 1.3% | 35 |
|
|
2025
Q4 | $6.22M | Sell |
78,750
-357
| -0.5% | -$28K | 1.42% | 35 |
|
|
2025
Q3 | $6.32M | Buy |
79,107
+11,553
| +17% | +$986K | 1.47% | 33 |
|
|
2025
Q2 | $6.14M | Sell |
67,554
-1,395
| -2% | -$127K | 1.5% | 32 |
|
|
2025
Q1 | $6.46M | Buy |
68,949
+2,516
| +4% | +$225K | 1.64% | 31 |
|
|
2024
Q4 | $6.04M | Sell |
66,433
-3,364
| -5% | -$321K | 1.56% | 30 |
|
|
2024
Q3 | $7.25M | Sell |
69,797
-4,613
| -6% | -$470K | 1.86% | 26 |
|
|
2024
Q2 | $7.22M | Sell |
74,410
-1,550
| -2% | -$143K | 2.01% | 21 |
|
|
2024
Q1 | $6.84M | Sell |
75,960
-170
| -0.2% | -$14.4K | 1.99% | 24 |
|
|
2023
Q4 | $6.07M | Buy |
76,130
+200
| +0.3% | +$15K | 1.92% | 28 |
|
|
2023
Q3 | $5.4M | Buy |
75,930
+1,623
| +2% | +$121K | 1.88% | 26 |
|
|
2023
Q2 | $5.72M | Buy |
74,307
+18,154
| +32% | +$1.41M | 1.93% | 25 |
|
|
2023
Q1 | $4.22M | Buy |
56,153
+18,243
| +48% | +$1.36M | 1.43% | 37 |
|
|
2022
Q4 | $2.99M | Sell |
37,910
-19,310
| -34% | -$1.45M | 1.03% | 48 |
|
|
2022
Q3 | $4.02M | Buy |
+57,220
| New | +$4.49M | 1.5% | 36 |
|
|
2021
Q1 | – | Sell |
-26,782
| Closed | -$2.29M | – | 69 |
|
|
2020
Q4 | $2.29M | Buy |
26,782
+850
| +3% | +$70.3K | 1% | 44 |
|
|
2020
Q3 | $2M | Buy |
25,932
+4,402
| +20% | +$336K | 0.96% | 44 |
|
|
2020
Q2 | $1.58M | Buy |
21,530
+20
| +0.1% | +$1.42K | 0.83% | 46 |
|
|
2020
Q1 | $1.43M | Sell |
21,510
-115
| -0.5% | -$8.11K | 0.86% | 47 |
|
|
2019
Q4 | $1.49M | Buy |
21,625
+830
| +4% | +$56.6K | 0.75% | 53 |
|
|
2019
Q3 | $1.53M | Sell |
20,795
-70
| -0.3% | -$5.08K | 0.83% | 52 |
|
|
2019
Q2 | $1.5M | Buy |
20,865
+385
| +2% | +$27.3K | 0.85% | 52 |
|
|
2019
Q1 | $1.4M | Buy |
20,480
+1,590
| +8% | +$103K | 0.85% | 52 |
|
|
2018
Q4 | $1.12M | Sell |
18,890
-5,105
| -21% | -$319K | 0.78% | 52 |
|
|
2018
Q3 | $1.61M | Buy |
23,995
+1,870
| +8% | +$125K | 0.98% | 49 |
|
|
2018
Q2 | $1.43M | Buy |
22,125
+880
| +4% | +$57.6K | 0.94% | 52 |
|
|
2018
Q1 | $1.52M | Buy |
21,245
+4,100
| +24% | +$295K | 1% | 52 |
|
|
2017
Q4 | $1.29M | Buy |
+17,145
| New | +$1.25M | 0.87% | 51 |
|
Other funds holding CL
Stokes Capital Advisors's CL Position: Q2 2026 in Review
Stokes Capital Advisors reduced its Colgate-Palmolive (CL) stake by 47% in Q2 2026, selling an estimated $2.83M and leaving 35,871 shares worth $3.29M. The position accounts for 0.7% of the portfolio, ranked #51.
Stokes Capital Advisors first reported a position in CL in Q4 2017 and has held it in 29 quarters since. The position peaked at $7.25M in Q3 2024. 2,017 funds tracked by Wall St. Rank hold CL as of Q2 2026.
- Stokes Capital Advisors held 35,871 shares of Colgate-Palmolive worth $3.29M as of Q2 2026.
- Stokes Capital Advisors sold 32,379 Colgate-Palmolive shares in Q2 2026, an estimated $2.83M.
- Colgate-Palmolive made up 0.7% of Stokes Capital Advisors's portfolio in Q2 2026, its #51 holding.
- Stokes Capital Advisors first reported a position in Colgate-Palmolive in Q4 2017 and has held it in 29 quarters since.
- Stokes Capital Advisors's Colgate-Palmolive position peaked at $7.25M in Q3 2024.
- 2,017 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.
Based on Stokes Capital Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.